These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 10199459)
1. Late recurrence of childhood acute lymphoblastic leukemia. Geetha N; Lali VS; Nileena N; Nair MK Am J Clin Oncol; 1999 Apr; 22(2):191-2. PubMed ID: 10199459 [TBL] [Abstract][Full Text] [Related]
2. Lower leukocytes at initial diagnosis may predict poor outcome of very late relapse of acute lymphoblastic leukemia. Nakasone H; Kida M; Iki S; Usuki K Leuk Res; 2008 Apr; 32(4):659-64. PubMed ID: 17850867 [TBL] [Abstract][Full Text] [Related]
3. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol]. Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166 [TBL] [Abstract][Full Text] [Related]
5. Late relapse in a case of childhood acute lymphoblastic leukemia. Lodha R; Jain Y; Pemde H; Bhargava M; Arya LS Indian Pediatr; 1998 Mar; 35(3):281-3. PubMed ID: 9707888 [No Abstract] [Full Text] [Related]
6. Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse? Aricò M; Germano G; del Giudice L; Ziino O; Locatelli F; Basso G Haematologica; 2002 Apr; 87(4):ELT19. PubMed ID: 11940504 [No Abstract] [Full Text] [Related]
8. Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia. Henze G; Fengler R; Hartmann R; Dopfer R; Göbel U; Graf N; Jürgens H; Niethammer D; Ritter J; Schellong G Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S16-9. PubMed ID: 2667787 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal presentation of late acute lymphoblastic leukemia relapse. Papadakis V; Roma E; Stefanaki K; Panagiotou I; Papargyri S; Paterakis G; Polychronopoulou S Pediatr Int; 2010 Jun; 52(3):e171-4. PubMed ID: 20723121 [No Abstract] [Full Text] [Related]
10. Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG). Kato M; Manabe A; Saito AM; Koh K; Inukai T; Ogawa C; Goto H; Tsuchida M; Ohara A Int J Hematol; 2015 Jan; 101(1):52-7. PubMed ID: 25432437 [TBL] [Abstract][Full Text] [Related]
11. Very late relapse cases of TCF3-ZNF384-positive acute lymphoblastic leukemia. Nishimura A; Hasegawa D; Hirabayashi S; Kanabuchi S; Yamamoto K; Aiga S; Nishitani M; Hosoya Y; Noguchi Y; Ohki K; Kiyokawa N; Mori S; Manabe A Pediatr Blood Cancer; 2019 Nov; 66(11):e27891. PubMed ID: 31347769 [No Abstract] [Full Text] [Related]
12. [Treatment and prognosis after late relapse in childhood acute lymphoblastic leukemia]. Ikuta K; Fujioka K; Takahashi H; Sumita H; Sekiguchi H; Hanzawa N; Kai S; Kajigaya Y; Funabiki T; Okuyama T Rinsho Ketsueki; 1993 Jun; 34(6):712-7. PubMed ID: 8366572 [TBL] [Abstract][Full Text] [Related]
13. Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86. Ludwig WD; Harbott J; Bartram CR; Komischke B; Sperling C; Teichmann JV; Seibt-Jung H; Notter M; Odenwald E; Nehmer A Recent Results Cancer Res; 1993; 131():269-82. PubMed ID: 8210646 [No Abstract] [Full Text] [Related]
14. Interferon-alpha treatment as a possible cause of relapse in a child with precursor B acute lymphoblastic leukemia. Söker M; Dikici B; Devecioglu C; Ece A; Haspolat K J Pediatr Hematol Oncol; 2001 May; 23(4):256-7. PubMed ID: 11846309 [No Abstract] [Full Text] [Related]
15. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report). Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294 [TBL] [Abstract][Full Text] [Related]
16. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia. Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515 [TBL] [Abstract][Full Text] [Related]
17. AC133 expression in egyptian children with acute leukemia: impact on treatment response and disease outcome. Elgendi HM; Mekawy MA; Abdel Wahab SE; Tawfik LM; Ismail EA; Adly AA J Pediatr Hematol Oncol; 2010 May; 32(4):286-93. PubMed ID: 20224439 [TBL] [Abstract][Full Text] [Related]
18. Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia. Xu XJ; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Xu WQ Leuk Res; 2012 Aug; 36(8):1022-7. PubMed ID: 22483330 [TBL] [Abstract][Full Text] [Related]
19. ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center. Kocak U; Gursel T; Kaya Z; Aral YZ; Albayrak M; Keskin EY; Belen B; Isık M; Oner N Pediatr Hematol Oncol; 2012 Mar; 29(2):130-40. PubMed ID: 22376016 [TBL] [Abstract][Full Text] [Related]
20. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol. Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]